ClinicalTrials.Veeva

Menu

Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma

Fudan University logo

Fudan University

Status

Unknown

Conditions

Glycolysis
Survival
Diagnosis
Lung Cancer

Treatments

Diagnostic Test: Diagnostic test

Study type

Observational

Funder types

Other

Identifiers

NCT03641105
ZST-GLUMETA

Details and patient eligibility

About

Detect the contents of glucose metabolism molecules in the tumor and adjacent normal samples of about 100 patients with lung adenocarcinoma using mass spectroscopy. Analyze the correlation between the contents and the clinicopathological characteristics and survival.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary lung adenocarcinoma

Exclusion criteria

  • Other tumor histories, received radiotherapy or chemotherapy before surgery, tumor or adjacent normal tissues can't be obtained, patient rejected.

Trial design

100 participants in 1 patient group

lung adenocarcinoma
Description:
patients with lung adenocarcinoma
Treatment:
Diagnostic Test: Diagnostic test

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems